| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030920017 |
| P356 | DOI | 10.1038/SJ.BJC.6600511 |
| P932 | PMC publication ID | 2364238 |
| P698 | PubMed publication ID | 12237773 |
| P5875 | ResearchGate publication ID | 11152534 |
| P2093 | author name string | A Lowy | |
| C Rochlitz | |||
| L Terracciano | |||
| R Herrmann | |||
| J Reuter | |||
| M Lagrange | |||
| U Laffer | |||
| J L Boulay | |||
| G Mild | |||
| P2860 | cites work | The Sequence of the Human Genome | Q22065842 |
| MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma | Q24315119 | ||
| Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability | Q24319995 | ||
| Surfing the p53 network | Q28032484 | ||
| Role of transforming growth factor beta in human disease | Q28143408 | ||
| Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling | Q28251743 | ||
| Genetic alterations during colorectal-tumor development | Q28281200 | ||
| Assignment1 of the Smad7 gene (MADH7) to human chromosome 18q21.1 by fluorescence in situ hybridization | Q28281575 | ||
| Molecular predictors of survival after adjuvant chemotherapy for colon cancer | Q28363159 | ||
| Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components | Q29036482 | ||
| DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 | Q29616726 | ||
| Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. | Q33964215 | ||
| Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-beta family ligands, receptors and Smad signal transducers | Q34607080 | ||
| Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line | Q35726298 | ||
| Thymineless death in colon carcinoma cells is mediated via fas signaling | Q36302971 | ||
| Resistance of human squamous carcinoma cells to transforming growth factor beta 1 is a recessive trait | Q36404409 | ||
| Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers. | Q36618842 | ||
| A breakpoint map of recurrent chromosomal rearrangements in human neoplasia | Q40899125 | ||
| Regulation of apoptosis induced by transforming growth factor-beta1 in nontumorigenic rat prostatic epithelial cell lines | Q41151156 | ||
| SMADs: mediators and regulators of TGF-beta signaling | Q41732765 | ||
| Survival and acquired genetic alterations in colorectal cancer. | Q45192274 | ||
| Nomenclature: vertebrate mediators of TGFbeta family signals | Q48058869 | ||
| Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. | Q53445992 | ||
| Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers | Q71167724 | ||
| Allelic loss of chromosome 18q and prognosis in colorectal cancer | Q72024722 | ||
| Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK) | Q72519129 | ||
| Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7 | Q73969923 | ||
| Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer | Q74606005 | ||
| Gene dosage by quantitative real-time PCR | Q78159554 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| colorectal cancer | Q188874 | ||
| chemotherapy | Q974135 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 630-4 | |
| P577 | publication date | 2002-09-09 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer | |
| P478 | volume | 87 |
| Q37416802 | Biology of BMP signalling and cancer. |
| Q60046390 | Biomarkers in colorectal cancer: Current clinical utility and future perspectives |
| Q27612411 | CIViC database |
| Q60629772 | Cancer colorectal : altérations moléculaires pronostiques |
| Q93014383 | Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma |
| Q38124901 | Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis |
| Q34425013 | Colorectal cancer molecular biology moves into clinical practice |
| Q34535747 | Common critical pathways in embryogenesis and cancer |
| Q55038614 | Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. |
| Q33842842 | Downregulated USP3 mRNA functions as a competitive endogenous RNA of SMAD4 by sponging miR-224 and promotes metastasis in colorectal cancer |
| Q38680776 | Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer |
| Q37523207 | Genetic prognostic and predictive markers in colorectal cancer |
| Q28658552 | Imagine a world without cancer |
| Q42560736 | Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer. |
| Q37386625 | Inhibition of pancreatic carcinoma cell growth in vitro by DPC4 gene transfection |
| Q36549454 | Links between biology, prognosis and prediction of response to chemotherapy in colorectal cancer. |
| Q33281073 | Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks |
| Q35111158 | Modern management of colorectal cancer--a pathologist's view. |
| Q26862317 | Molecular alterations and biomarkers in colorectal cancer |
| Q57037017 | Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma |
| Q53299071 | Mononucleotide repeats in the SMAD4 gene promoter in colon carcinoma tissue of Croatian patients. |
| Q37132653 | Predictive and prognostic factors in colorectal cancer: a personalized approach |
| Q28261456 | Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer |
| Q33834425 | Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma |
| Q35134629 | Quantitative real-time PCR: a powerful ally in cancer research. |
| Q43775981 | SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastases |
| Q52936646 | SMAD4 gene promoter mutations in patients with thyroid tumors. |
| Q34079958 | SMAD4 is a potential prognostic marker in human breast carcinomas. |
| Q34928876 | STRAP is a strong predictive marker of adjuvant chemotherapy benefit in colorectal cancer. |
| Q35218771 | Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival |
| Q39957865 | TGF-beta has paradoxical and context dependent effects on proliferation and anoikis in human colorectal cancer cell lines |
| Q35587027 | The role of SMAD4 in early-onset colorectal cancer |
| Q52688883 | The role of TGF-β/SMAD4 signaling in cancer. |
| Q28274343 | The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer |
| Q37130603 | The role of personalized medicine in metastatic colorectal cancer: an evolving landscape |
| Q38762901 | Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer |
| Q47113925 | Upregulation of NETO2 gene in colorectal cancer |
Search more.